Serum levels of Fas/Apo-1 and bcl-2 in children with HIV-1 infection

被引:0
|
作者
Torre, D [1 ]
Zeroli, C [1 ]
Speranza, F [1 ]
Martegani, R [1 ]
Fiori, G [1 ]
Airoldi, M [1 ]
机构
[1] Reg Hosp & Fdn Macchi, Div Infect Dis, IT-21100 Varese, Italy
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Apoptosis of CD4-positive T cells is considered to he in,ol, ed in depletion of CD4-positive T cells in adult patients with HIV-1 infection, In this report we evaluated serum levels of soluble Fas/Apo-1 and circulating bcl-2 protein (an antiapoptotic molecule) in HIV-1-infected children, acid 30 HIV-1 seronegative children. Significantly higher levels of Fas/Apo-1 were observed in 13 HIV-1-infected children than in non-infected control children (p < 0.001), whereas serum levels of bcl-2 were significantly decreased (p = 0.002). Seronegative children born to HIV-infected mothers displayed significantly decreased (p < 0.05) serum levels of bcl-2. By contrast, children born to HIV-seronegative mothers and suffering from acute lower respirator! infection had normal lo-cls of bcl-2 and Fas/Apo-1. These data suggest that upregulation of Fas/Apo-1 along with downregulation of bcl-2 protein may contribute to apoptosis in children with HIV-1 infection.
引用
收藏
页码:565 / 568
页数:4
相关论文
共 50 条
  • [21] Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma
    R Maruyama
    K Yamana
    T Itoi
    N Hara
    V Bilim
    T Nishiyama
    K Takahashi
    Y Tomita
    British Journal of Cancer, 2006, 95 : 1244 - 1249
  • [22] 急性白血病细胞bcl-2、Bax和Fas/Apo-1基因表达的研究
    刘月波
    何勤
    刘琳
    毕慧
    中国实验诊断学, 2003, (02) : 102 - 105
  • [23] Levels of soluble Fas/APO-1 in patients with Behcet's disease
    Hamzaoui, K
    Hamzaoui, A
    Zakraoui, L
    Chabbou, A
    MEDIATORS OF INFLAMMATION, 1998, 7 (02) : 111 - 114
  • [24] Elevated serum levels of soluble Fas/APO-1 in human immunodeficiency virus-infected individuals
    Fadeel, B
    Samuelsson, A
    Hachiya, T
    Brostrom, C
    Chiodi, F
    BLOOD, 1996, 88 (12) : 4727 - 4730
  • [25] Fas/Apo-1 and oxidative stress in ageing
    Kim, Y
    Lee, N
    Won, D
    Suh, J
    Song, K
    CLINICAL CHEMISTRY, 2005, 51 : A73 - A73
  • [26] Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus Type 1 (HIV-1)-infected children
    Kirstin Stricker
    Eckart Knipping
    Thomas Böhler
    Axel Benner
    Peter H Krammer
    Klaus-Michael Debatin
    Cell Death & Differentiation, 1998, 5 : 222 - 230
  • [27] Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma
    Jodo, S
    Kobayashi, S
    Nakajima, Y
    Matsunaga, T
    Nakayama, N
    Ogura, N
    Kayagaki, N
    Okumura, K
    Koike, T
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 112 (02): : 166 - 171
  • [28] Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children
    Stricker, K
    Knipping, E
    Böhler, T
    Benner, A
    Krammer, PH
    Debatin, KM
    CELL DEATH AND DIFFERENTIATION, 1998, 5 (03): : 222 - 230
  • [29] Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients
    Ciusani, E
    Frigerio, S
    Gelati, M
    Corsini, E
    Dufour, A
    Nespolo, A
    La Mantia, L
    Milanese, C
    Massa, G
    Salmaggi, A
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 82 (01) : 5 - 12
  • [30] Circulating levels of FAS/APO-1 in patients with the systemic inflammatory response syndrome
    Torre, D
    Tambini, R
    Manfredi, M
    Mangani, V
    Livi, P
    Maldifassi, V
    Campi, P
    Speranza, F
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 45 (04) : 233 - 236